Lannett gets a nod from the FDA

Discussion in 'Lannett' started by RobertPhillips900, Sep 5, 2017 at 5:29 PM.

  1. RobertPhillips900

    Joined:
    Aug 29, 2016
    Messages:
    51
    Likes Received:
    0
    $LCI said it won the U.S. FDA's approval for its Abbreviated New Drug Application (ANDA) for Esomeprazole Magnesium Delayed-Release Capsules, USP in the strengths of 20mg and 40mg. This is used to treat gastroesophageal reflux disease.
     

  2. anonymous

    anonymous Guest

    How is it Lannett promoted ctopical by two sales forces and promoted off the label prior FDA approval? I had a guy come into our office showing us a video promoting the vasoconstriction benefits? Where is the label?
     
  3. anonymous

    anonymous Guest

    Lannett hired sales force in 2016 and launched ctopical without FDA approval. I am unsure how happened. With opioid crisis and risks was questionable why a Sales Team was out promoting without Pi and showing video for vasoconstriction benefits in emergency environment. Was FDA aware?
     
  4. anonymous

    anonymous Guest

    It was supposedly grandfathered in. And there was a PI. Why are you stirring this empty pot?
     
  5. anonymous

    anonymous Guest

    As a patient with nose bleeds I would not want a practitioner putting a non FDA approved narcotic in my nose. If something would happen like death from heart attack or bad reaction I would demand answers immediately so to answer your pathetic question why stir pot that’s answer
     
  6. anonymous

    anonymous Guest

    Can someone please explain why a narcotic as cocaine is ctopical? I would have no toleration of acceptance being given a non FDA approved narcotic especially if a negative reaction happened!